Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 35, Issue 8, pp 1407–1417 | Cite as

Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes

  • Karel Souček
  • Alice Malenovská
  • Zuzana Kahounová
  • Ján Remšík
  • Zuzana Holubcová
  • Tomáš Soukup
  • Daniela Kurfürstová
  • Jan Bouchal
  • Tereza Suchánková
  • Eva Slabáková
  • Aleš Hampl
Reproductive Physiology and Disease

Abstract

Purpose

The purpose of the study was to determine whether the GDF-15 is present in follicular fluid; to evaluate if there is a relation between follicular and serum levels of GDF-15 and fertility status of study subjects; and to test whether granulosa cells, oocytes, or both produce GDF-15.

Methods

This study used follicular fluid (FF, serum, and oocytes obtained under informed consent from women undergoing oocyte retrieval for in vitro fertilization. It also used ovaries from deceased preterm newborns. Collection of FF and blood at the time of oocyte retrieval, ELISA and western blot were performed to determine levels and forms of GDF-15. Concentrations of GDF-15 in FF and serum, its expression in ovarian tissue, and secretion from granulosa cells were analyzed.

Results

GDF-15 concentration in FF ranged from 35 to 572 ng/ml, as determined by ELISA. Western blot analysis revealed the GDF-15 pro-dimer only in FF. Both normal healthy and cancerous granulosa cells secreted GDF-15 into culture media. Primary oocytes displayed cytoplasmic GDF-15 positivity in immunostained newborn ovaries, and its expression was also observed in fully grown human oocytes.

Conclusions

To the best of our knowledge, this is the first documentation of cytokine GDF-15 presence in follicular fluid. Its concentration was not associated with donor/patient fertility status. Our data also show that GDF-15 is expressed and inducible in both normal healthy and cancerous granulosa cells, as well as in oocytes.

Keywords

Follicular fluid Growth/differentiation factor-15 Follicular granulosa cells IVF 

Notes

Acknowledgements

The authors would like to thank Iva Lišková, Martina Urbánková, and Kateřina Svobodová for their superb technical assistance; Petra Ovesná for helping with statistical analyses, Monika Smějová, and Veronika Toporcerová for helping with protein quantifications and for western blot analyses respectively.

Author’s roles

KS carried out ELISA procedures and conceptualized the study, contributing to its design, coordination, and manuscript draft. Tsu and JR performed western blot testing; ZK and ES conducted qRT-PCR analysis, and IHC analysis was undertaken by JB and DK. TSo established the primary granulosa cell lines. AM and ZH completed sample preparation. AH participated in study design and with ES helped to draft the manuscript. All authors have read and approved the final manuscript.

Funding

This work was supported by the following grants: 15-11707S from Czech Science Foundation, by Ministry of Health of the Czech Republic, grant no. 15-33999A, all rights reserved (KS); project PROGRES Q40/06 (Charles University [TSo]); project mobility no. 7AMB16AT022 from the Ministry of Education, Youth and Sports; project HistoPARK (CZ.1.07/2.3.00/20.0185, [KS, AH]), CELLBIOL (CZ.1.07/2.3.00/30.0030 [TS]); project no. LQ1605 from the National Program of Sustainability II (MEYS CR; KS, AH); project no. LO1304 from the National Program of Sustainability I (MEYS CR; JB, DK); and the European Union—project ICRC-ERA-HumanBridge (no. 316345; KS, AH).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10815_2018_1230_MOESM1_ESM.pdf (653 kb)
ESM 1 Supplementary Fig. 1 Flow-chart diagram. Supplementary Fig. 2 Validation of the anti-GDF15 antibody was performed on formalin-fixed paraffin-embedded cell lines with known expression of GDF15. High (LNCaP cell line) and low expression (BPH1 cell line) of GDF15 was detected both by immunohistochemistry and western blotting. Magnification 200X, scale bars represent 50 μm. Supplementary Fig. 3 Immunohistochemical staining of HIF-1α in the ovary from the preterm newborn 2. The staining pattern of some follicles is different from the preterm newborn 1, probably due to longer time to autopsy (the autopsies were performed 28 and 47 h after exitus of newborns 1 and 2, respectively). Importantly, the staining pattern of both HIF-1α and GDF15 in the cytoplasm of oocytes is similar in both cases (please compare to the Fig. 3). Magnification 400X, scale bar represents 20 μm. Supplementary Table 1. Results of T-test of donor vs. patient characteristics. (PDF 652 kb)

References

  1. 1.
    Revelli A, Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol. 2009;7(1):40.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Ambekar AS, Nirujogi RS, Srikanth SM, Chavan S, Kelkar DS, Hinduja I, et al. Proteomic analysis of human follicular fluid: a new perspective towards understanding folliculogenesis. J Proteome. 2013;87:68–77.  https://doi.org/10.1016/j.jprot.2013.05.017.CrossRefGoogle Scholar
  3. 3.
    Rodgers RJ, Irving-Rodgers HF. Formation of the ovarian follicular antrum and follicular fluid. Biol Reprod. 2010;82(6):1021–9.  https://doi.org/10.1095/biolreprod.109.082941.CrossRefPubMedGoogle Scholar
  4. 4.
    Field SL, Dasgupta T, Cummings M, Orsi NM. Cytokines in ovarian folliculogenesis, oocyte maturation and luteinisation. Mol Reprod Dev. 2014;81(4):284–314.  https://doi.org/10.1002/mrd.22285.CrossRefPubMedGoogle Scholar
  5. 5.
    Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-β superfamily expression and actions in the endometrium and placenta. Reproduction. 2006;132(2):217–32.  https://doi.org/10.1530/rep.1.01076.CrossRefPubMedGoogle Scholar
  6. 6.
    Soucek K, Slabakova E, Ovesna P, Malenovska A, Kozubik A, Hampl A. Growth/differentiation factor-15 is an abundant cytokine in human seminal plasma. Hum Reprod. 2010;25(12):2962–71.  https://doi.org/10.1093/humrep/deq264.CrossRefPubMedGoogle Scholar
  7. 7.
    Corre J, Hébraud B, Bourin P. Concise review: growth differentiation factor 15 in pathology: a clinical role? Stem Cells Transl Med. 2013;2(12):946–52.  https://doi.org/10.5966/sctm.2013-0055.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Tsai VW, Lin S, Brown DA, Salis A, Breit SN. Anorexia–cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15. Int J Obes. 2016;40(2):193–7.  https://doi.org/10.1038/ijo.2015.242.CrossRefGoogle Scholar
  9. 9.
    Yang L, Chang CC, Sun Z, Madsen D, Zhu H, Padkjaer SB, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23(10):1158–66.  https://doi.org/10.1038/nm.4394.CrossRefPubMedGoogle Scholar
  10. 10.
    Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017;23(10):1215–9.  https://doi.org/10.1038/nm.4393.CrossRefPubMedGoogle Scholar
  11. 11.
    Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017;550(7675):255–9.  https://doi.org/10.1038/nature24042.CrossRefPubMedGoogle Scholar
  12. 12.
    Xiong Y, Walker K, Min X, Hale C, Tran T, Komorowski R, et al. Long-acting MIC-1/GDF15 molecules to treat obesity: evidence from mice to monkeys. Sci Transl Med. 2017;9(412):eaan8732.  https://doi.org/10.1126/scitranslmed.aan8732.CrossRefPubMedGoogle Scholar
  13. 13.
    Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A. 1997;94(21):11514–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol. 1999;65(1):2–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Abd El-Aziz SH, Endo Y, Miyamaori H, Takino T, Sato H. Cleavage of growth differentiation factor 15 (GDF15) by membrane type 1-matrix metalloproteinase abrogates GDF15-mediated suppression of tumor cell growth. Cancer Sci. 2007;98(9):1330–5.  https://doi.org/10.1111/j.1349-7006.2007.00547.x.CrossRefPubMedGoogle Scholar
  16. 16.
    Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, et al. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res. 2005;65(6):2330–6.  https://doi.org/10.1158/0008-5472.can-04-3827.CrossRefPubMedGoogle Scholar
  17. 17.
    Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res. 2004;318(2):325–33.  https://doi.org/10.1007/s00441-004-0986-3.CrossRefPubMedGoogle Scholar
  18. 18.
    Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, et al. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation. Circulation. 2014;130(21):1847–58.CrossRefPubMedGoogle Scholar
  19. 19.
    Attaran M, Pasqualotto E, Falcone T, Goldberg JM, Miller KF, Agarwal A, et al. The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int J Fertil Womens Med. 2000;45(5):314–20.PubMedGoogle Scholar
  20. 20.
    Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10(1):49.  https://doi.org/10.1186/1477-7827-10-49.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Gupta S, Ghulmiyyah J, Sharma R, Halabi J, Agarwal A. Power of proteomics in linking oxidative stress and female infertility. Biomed Res Int. 2014;2014:26.  https://doi.org/10.1155/2014/916212.CrossRefGoogle Scholar
  22. 22.
    Zamah AM, Hassis ME, Albertolle ME, Williams KE. Proteomic analysis of human follicular fluid from fertile women. Clin Proteomics. 2015;12(1):5.  https://doi.org/10.1186/s12014-015-9077-6.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Bruckova L, Soukup T, Visek B, Moos J, Moosova M, Pavelkova J, et al. Proliferative potential and phenotypic analysis of long-term cultivated human granulosa cells initiated by addition of follicular fluid. J Assist Reprod Genet. 2011;28(10):939–50.  https://doi.org/10.1007/s10815-011-9617-6.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Bruckova L, Soukup T, Moos J, Moosova M, Pavelkova J, Rezabek K, et al. The cultivation of human granulosa cells. Acta Med Austriaca. 2008;51(3):165–72.Google Scholar
  25. 25.
    van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH, et al. Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. Int J Cancer. 1993;53(4):613–20.CrossRefPubMedGoogle Scholar
  26. 26.
    Pernicová Z, Slabáková E, Kharaishvili G, Bouchal J, Král M, Kunická Z, et al. Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2. Neoplasia. 2011;13(6):526–36.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Slabakova E, Pernicova Z, Slavickova E, Starsichova A, Kozubik A, Soucek K. TGF-beta 1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug. Prostate. 2011;71(12):1332–43.  https://doi.org/10.1002/pros.21350.PubMedCrossRefGoogle Scholar
  28. 28.
    Bauskin AR, Zhang HP, Fairlie WD, He XY, Russell PK, Moore AG, et al. The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J. 2000;19(10):2212–20.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004;303(5659):844–8.  https://doi.org/10.1126/science.1092472.CrossRefPubMedGoogle Scholar
  30. 30.
    Database PC. Cytarabine. National Center for Biotechnology Information. 2017. https://pubchem.ncbi.nlm.nih.gov/compound/6253 Accessed Apr 19 2017.
  31. 31.
    Ambekar AS, Kelkar DS, Pinto SM, Sharma R, Hinduja I, Zaveri K, et al. Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development. J Clin Endocrinol Metab. 2015;100(2):744–53.  https://doi.org/10.1210/jc.2014-2086.CrossRefPubMedGoogle Scholar
  32. 32.
    Fahiminiya S, Labas V, Roche S, Dacheux J-L, Gérard N. Proteomic analysis of mare follicular fluid during late follicle development. Proteome Sci. 2011;9(1):54.  https://doi.org/10.1186/1477-5956-9-54.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Oh JW, Kim SK, Cho K-C, Kim M-S, Suh CS, Lee JR, et al. Proteomic analysis of human follicular fluid in poor ovarian responders during in vitro fertilization. Proteomics. 2017;17(6):1600333-n/a.  https://doi.org/10.1002/pmic.201600333.CrossRefGoogle Scholar
  34. 34.
    Moos J, Filova V, Pavelkova J, Moosova M, Peknicova J, Rezabek K. Follicular fluid and serum levels of Inhibin A and pregnancy-associated plasma protein A in patients undergoing IVF. Fertil Steril. 2009;91(5):1739–44.  https://doi.org/10.1016/j.fertnstert.2008.01.102.CrossRefPubMedGoogle Scholar
  35. 35.
    Lee M-S, Tzeng S-L, Yang S-F, Lin Y-P, Cheng E-H, Huang C-C, et al. Correlation of serum anti-Mullerian hormone to follicular follicle stimulating hormone and implantation potential of the ensuing embryos. Clin Chim Acta. 2017;471:327–33.  https://doi.org/10.1016/j.cca.2017.06.023.CrossRefPubMedGoogle Scholar
  36. 36.
    Fried G, Remaeus K, Harlin J, Krog E, Csemiczky G, Aanesen A, et al. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. J Assist Reprod Genet. 2003;20(5):167–76.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Tsai VW-W, Macia L, Johnen H, Kuffner T, Manadhar R, Jørgensen SB, et al. TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator. PLoS One. 2013;8(2):e55174.  https://doi.org/10.1371/journal.pone.0055174.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Tsai VW-W, Macia L, Feinle-Bisset C, Manandhar R, Astrup A, Raben A, et al. Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMI. PLoS One. 2015;10(7):e0133362.  https://doi.org/10.1371/journal.pone.0133362.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, et al. Factors associated with oxidative stress in human populations. Am J Epidemiol. 2002;156(3):274–85.CrossRefPubMedGoogle Scholar
  40. 40.
    Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod. 2007;22(2):414–20.  https://doi.org/10.1093/humrep/del400.CrossRefPubMedGoogle Scholar
  41. 41.
    Li S, Wang Y, Cao B, Wu Y, Ji L, Li Y-x, et al. Maturation of growth differentiation factor 15 in human placental trophoblast cells depends on the interaction with matrix metalloproteinase-26. J Clin Endocrinol Metab. 2014;99(11):E2277–E87.  https://doi.org/10.1210/jc.2014-1598.CrossRefPubMedGoogle Scholar
  42. 42.
    Brown DA, Lindmark F, Stattin P, Balter K, Adami HO, Zheng SL, et al. Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res. 2009;15(21):6658–64.  https://doi.org/10.1158/1078-0432.CCR-08-3126.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Page RE, Klein-Szanto AJ, Litwin S, Nicolas E, Al-Jumaily R, Alexander P, et al. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol. 2007;29(4):289–99.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.  https://doi.org/10.1126/science.1260419.CrossRefPubMedGoogle Scholar
  45. 45.
    Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circul Res. 2006;98(3):342–50.  https://doi.org/10.1161/01.RES.0000202804.84885.d0.CrossRefGoogle Scholar
  46. 46.
    Kim K-K, Lee JJ, Yang Y, You K-H, Lee J-H. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis. 2008;29(4):704–12.  https://doi.org/10.1093/carcin/bgn031.CrossRefPubMedGoogle Scholar
  47. 47.
    Carrillo-García C, Prochnow S, Simeonova IK, Strelau J, Hölzl-Wenig G, Mandl C, et al. Growth/differentiation factor 15 promotes EGFR signalling, and regulates proliferation and migration in the hippocampus of neonatal and young adult mice. Development. 2014;141(4):773–83.  https://doi.org/10.1242/dev.096131.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institute of Biophysics of the Czech Academy of SciencesBrnoCzech Republic
  2. 2.International Clinical Research CenterSt. Anne’s University Hospital BrnoBrnoCzech Republic
  3. 3.Reprofit International Clinic of Reproductive MedicineBrnoCzech Republic
  4. 4.Department of Experimental Biology, Faculty of ScienceMasaryk UniversityBrnoCzech Republic
  5. 5.Department of Histology and Embryology, Faculty of MedicineMasaryk UniversityBrnoCzech Republic
  6. 6.Faculty of Medicine in Hradec Králové, Department of Histology and EmbryologyCharles University in PragueHradec KrálovéCzech Republic
  7. 7.Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and DentistryPalacky University OlomoucOlomoucCzech Republic

Personalised recommendations